<!DOCTYPE html>
<html class="theme-cyan cdc-page-type-content cdc-2020" lang="en-us">

<head>
    <meta http-equiv="content-type" content="text/html; charset=UTF-8">
	<meta charset="utf-8">
    
    <link rel="shortcut icon" href="favicon.ico">
    <link rel="stylesheet" href="home_files/bootstrap.css">
    <link rel="stylesheet" href="home_files/app.css">
       
	<title>ZF2001 Vaccine | COVID-19 Info Center</title>
    <meta name="description" content="ZF2001 Vaccine Page">
    <meta name="keywords" content="ZF2001">	
</head>

<body>
 
    <div class="container-fluid site-title">
    <div class="naviimage">
        <div class="container">
            <div class="row">
                <h3>L1-team06</h3>
            </div>
        </div>
	</div>
    </div>
  
    <div id="cdc-meganav-wrapper">
        
        <div class="container" id="cdc-meganav-bar">
            
            <nav class="navbar navbar-expand-xl yamm">
            
                <ul class="nav navbar-nav nav-justified w-100">
                  
                    <li class="nav-item" id="menu_home">
                        <a class="nav-link" href="home.html">
                            Home						
						</a>
                    </li>

                    <li class="nav-item" id="menu1">
                        <a class="nav-link" href="page1.html">
                            Pfizer-BioNTech Vaccine						
						</a>
                    </li>

                    <li class="nav-item" id="menu2">
                        <a class="nav-link" href="page2.html">
                            Johnson and Johnson Vaccine						
						</a>
                    </li>

                    <li class="nav-item" id="menu3">
                        <a class="nav-link active" href="page3.html">
                            ZF2001 Vaccine						
						</a>
                    </li>

                    <li class="nav-item" id="menu4">
                        <a class="nav-link" href="page4.html">
                            Sinovac Vaccine						
						</a>
                    </li>

                </ul>
            </nav>
        </div>
    </div>
	       
    <!-- Page Content Wrap -->
    <div class="container d-flex flex-wrap body-wrapper bg-white">
    
        <!-- Content -->
        <main class="col-xl-9 order-xl-2">
            <img src="home_files/temporarily excluded/cases_rising_banner_767x167_v5.png" alt="header">
            <div class="row">
            
                <div class="col content">
                
                    <div class="row">
                        <br>
                        <h2 id="content" class="open d-lg-block">Information about the ZF2001 COVID-19 Vaccine</h2>
                        <br>
                        <br>
                        <br>
                        
                    </div>
                    <div class="cdc-2020-bar container">
							
                    </div>
                 
                    <div class="syndicate">
                        <div class="row ">
                            <div class="col-md-12">
                                <div class="card border-0 rounded-0 mb-3">
                                    <div class="card-body bg-primary">
                                        <div class="row">
                                            <div class="d-none">
                                                <div class="text-center">
                                                    <img src="home_files/clipboard.png" alt="Clipboard with checkmarks" class="card-img-top img-fluid p-0 bg-primary card-img-orig d-none d-md-block rounded-0">
                                                </div>
                                            </div>
                                            <div class="col">
                                                <h3 class="card-title h3 mb-3 text-left">General information</h3>
                                                <p>
													ZF2001 or RBD-Dimer, is a protein subunit COVID-19 vaccine similar to Novavax, Vector Institure and Medicago that was developed by Anhui Zhifei Longcom in collaboration with the Institute of Microbiology at the Chinese Academy of Sciences. As of December 2020, the vaccine candidate was in Phase III trials with 29,000 participants in China, Ecuador, Malaysia, Pakistan, and Uzbekistan. The RBD-dimer significantly increases neutralizing antibodies compared to a conventional monomeric form and protected mice against MERS-CoV infection. Rather than injecting a whole virus, subunit vaccines contains virus particles specially selected to stimulate an immune response. Because the fragments are incapable of causing disease, subunit vaccines are considered very safe. The cons of taking this vaccine is that the inconvient for people to take this vaccine for a second or third doses in order for this vaccine to be effecive.		
												</p>
												<p>
													<ul><li> <b>Emergency Use Authorization Status:</b> Only authorized to few country which is Uzbekistan and China</li>
													<li><b>Name:</b> ZF2001 / RBD-Dimer </li>
													<li><b>Manufacturer:</b> Anhui Zhifei Longcom</li>
													<li><b>Number of Shots:</b> Three-dose over two months </li>
													<li><b>How given:</b> Shot in the intramuscular</b>
												</p>
                                               
                                            </div>
                                            <div class="pl-md-0 col-md-3 d-none d-md-block">
                                                <div class="text-center">
                                                    <img src="home_files/zf1.jfif" alt="zf2001 Vaccine" class="card-img-top img-fluid p-0 bg-primary card-img-orig d-none d-md-block rounded-0">
                                                </div>
                                            </div>
                                        </div>
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row ">
                            <div class="col-md-12">
                                <div class="row-fluid">
                                    <div class="vc_empty_space col-12 pt-3 pb-3">
                                        <span class="vc_empty_space_inner">
										</span>
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row ">
                            <div class="col-md-12">
                                <div class="color-bar cyan half">
                                    <div></div>
                                    <div></div>
                                    <div></div>
                                </div>
                                <div class="card border-0 rounded-0 mb-3">
                                    <div class="card-body ">
										<img src="home_files/zf2.png" alt="zf2001 Vaccine" class="card-img-top img-fluid p-0 bg-primary card-img-orig d-none d-md-block rounded-0">
                                        <br><h2 class="card-title h3 mb-3 text-left">Side Effects</h2>
                                        <p>Mild side-effect that can cause when taking this vaccine are: </p>
                                        <ul>
                                            <li>Injection pain.</li>
                                            <li>Redness.</li>
											<li>Swelling</li>	
                                        </ul>   
                                    </div>	
                                </div>
                            </div>
                        </div>
                        <div class="row ">
                            <div class="col-md-12">
                                <div class="card border-0 rounded-0">
                                    <div class="card-body bg-quaternary">
                                        <h2 class="card-title h3 mb-3 text-left">Information on how well the vaccine works</h2>
                                        <p>
										The combined data from Phase 1 and 2 trials involved 950 healthy Chinese participants aged 18-59. Low dose and high dose versions were tested, and the Phase 2 study also tested two doses versus three doses for both the low dose and high dose versions.<br><br>

										The higher dose given via three injections spaced 30 days apart did not induce an improved immune reponse compared to the lower dose, the paper said. The Phase 3 trial will look at the lower dose version given over three injections, it said.<br><br>

										Neutralising antibodies against the virus were detected among at least 93% participants who received three shots in different groups. The levels of vaccine-triggered antibodies were higher than those seen in samples of patients recovered from the disease, researchers said.<br><br>

										However, these antibody-based readings are on their own not sufficient to predict how effective ZF2001 will be in protecting people from the virus, researchers said, warning they could not yet determine the duration of immune responses<br>
										</p>

                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
							
          <br>
          <br>
          <br>
          
          <a href="registration_form1.php">Register for Vaccination</a> <br>
		  <a href="check.php">Check for your registration Vaccination</a>

          <br>
          <br>
          <br>
          
     
        </main>
    						
    </div> 
            
    <div class="container-fluid">
        <div class="container">
        
            <div class="card-body bg-quaternary">
                    
                <h5>Disclaimer</h5>
                <p style="font-size:14px;">This website is created mainly for educational and non-commercial use only. It is a 
                partial fulfillment for completion of unit SWE20001 - Development Project 1 offered in 
                Swinburne University of Technology, Sarawak Campus. The web-master and author(s) do not 
                represent the business entity. The content of the pages of this website might be out-dated 
                or inaccurate, thus, the author(s) and web-master does not take any responsibility for 
                incorrect information disseminated or cited from this website.</p>
                
            </div>
        </div>
    </div>
    
</body>
</html>